Evidence map›Paper›PMID 37100912›Full record

ArticleNature2023

A druggable copper-signalling pathway that drives inflammation.

Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, Antoine Versini, Arnaud Mansart, Fabien Sindikubwabo, Leeroy Baron, Laila Emam, Pierre Gestraud, G Dan Pantoș and 24 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 1 pooled it
47.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 1 synthesis or guideline pooled it, 294 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Genes, fuel, and fate in lung cancer.Biochemical Society transactions · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Copper dysregulation in cardiometabolic disease: copper deficiency versus cuproptosis.Apoptosis : an international journal on programmed cell death · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 6 institutions in 3 countries.

Stéphanie Solier *Equipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Sebastian Müller *Equipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.ORCID 0000-0002-3423-5364
Tatiana Cañeque *Equipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Antoine Versini *Equipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.ORCID 0000-0001-9799-2701
Arnaud MansartParis Saclay University, UVSQ, INSERM, 2I, Montigny-le-Bretonneux, France.
Fabien SindikubwaboEquipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.ORCID 0000-0002-9381-6302
Leeroy BaronEquipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Laila EmamParis Saclay University, UVSQ, INSERM, 2I, Montigny-le-Bretonneux, France.
Pierre GestraudCBIO-Centre for Computational Biology, Institut Curie, INSERM, Mines ParisTech, Paris, France.ORCID 0000-0002-3893-9879
G Dan PantoșDepartment of Chemistry, University of Bath, Bath, UK.
Vincent GandonInstitut de Chimie Moléculaire et des Matériaux d'Orsay, CNRS, Paris Saclay University, Orsay, France.ORCID 0000-0003-1108-9410
Christine GailletEquipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Ting-Di WuInstitut Curie, PSL Research University, Paris, France.
Florent DingliCurieCoreTech Mass Spectrometry Proteomic, Institut Curie, PSL Research University, Paris, France.ORCID 0000-0002-7715-2446
Damarys LoewCurieCoreTech Mass Spectrometry Proteomic, Institut Curie, PSL Research University, Paris, France.ORCID 0000-0002-9111-8842
Sylvain BaulandeICGex Next-Generation Sequencing Platform, Institut Curie, PSL Research University, Paris, France.ORCID 0000-0003-3104-1684
Sylvère DurandMetabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.
Valentin SencioUniversité de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, CIIL, Lille, France.ORCID 0000-0002-6379-4317
Cyril RobilUniversité de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, CIIL, Lille, France.ORCID 0000-0002-3607-244X
François TrotteinUniversité de Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, CIIL, Lille, France.ORCID 0000-0003-3373-1814
David PéricatInstitut of Pharmacology and Structural Biology, University of Toulouse, CNRS, Toulouse, France.
Emmanuelle NäserInstitut of Pharmacology and Structural Biology, University of Toulouse, CNRS, Toulouse, France.
Céline CougouleInstitut of Pharmacology and Structural Biology, University of Toulouse, CNRS, Toulouse, France.
Etienne MeunierInstitut of Pharmacology and Structural Biology, University of Toulouse, CNRS, Toulouse, France.
Anne-Laure BègueInstitut Curie, INSERM, PSL Research University, Paris, France.
Hélène SalmonInstitut Curie, INSERM, PSL Research University, Paris, France.
Nicolas ManelInstitut Curie, INSERM, PSL Research University, Paris, France.ORCID 0000-0002-1481-4430
Alain PuisieuxEquipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France.
Sarah WatsonDepartment of Medical Oncology, Institut Curie, PSL Research University, Paris, France.ORCID 0000-0003-4534-8783
Mark A DawsonPeter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, Melbourne, Victoria, Australia.ORCID 0000-0002-5464-5029
Nicolas ServantCBIO-Centre for Computational Biology, Institut Curie, INSERM, Mines ParisTech, Paris, France.ORCID 0000-0003-1678-7410
Guido KroemerMetabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.ORCID 0000-0002-9334-4405
Djillali AnnaneParis Saclay University, UVSQ, INSERM, 2I, Montigny-le-Bretonneux, France.
Raphaël RodriguezEquipe Labellisée Ligue Contre le Cancer, Institut Curie, CNRS, INSERM, PSL Research University, Paris, France. raphael.rodriguez@curie.fr.ORCID 0000-0001-7668-446X
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Paris Sciences et Lettres · FRInstitut Gustave Roussy · FRThe University of Melbourne · AUUniversity of Bath · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a complex physiological process triggered in response to harmful stimuli

Indexed as

Cell PlasticityCopperInflammationSignal TransductionAnimalsEpigenesis, GeneticHyaluronan ReceptorsHydrogen PeroxideMacrophage ActivationMacrophagesMetforminMiceMitochondriaNADOxidation-ReductionCd44 protein, mouseCopperHyaluronan ReceptorsHydrogen PeroxideMetforminNAD

Identifiers

PMID37100912
PMCPMC10131557
OpenAlexW4367049738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.